1. Home
  2. BGIN vs LRMR Comparison

BGIN vs LRMR Comparison

Compare BGIN & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BGIN

Bgin Blockchain Limited Class A Ordinary Shares

N/A

Current Price

$2.92

Market Cap

332.6M

Sector

N/A

ML Signal

N/A

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$3.16

Market Cap

280.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGIN
LRMR
Founded
2019
N/A
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
332.6M
280.0M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
BGIN
LRMR
Price
$2.92
$3.16
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$16.50
AVG Volume (30 Days)
15.4K
1.1M
Earning Date
03-02-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$205,457,324.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.38
$1.61
52 Week High
$6.50
$5.37

Technical Indicators

Market Signals
Indicator
BGIN
LRMR
Relative Strength Index (RSI) 44.96 40.26
Support Level $2.89 $3.06
Resistance Level $3.04 $3.40
Average True Range (ATR) 0.13 0.21
MACD -0.03 -0.02
Stochastic Oscillator 23.30 12.86

Price Performance

Historical Comparison
BGIN
LRMR

About BGIN Bgin Blockchain Limited Class A Ordinary Shares

BGIN Blockchain Ltd is operating through its subsidiaries and is engaged in digital asset technology company based in Singapore, Hong Kong and the U.S. with proprietary cryptocurrency-mining technologies and a strategic focus on alternative cryptocurrencies. It design and sell mining machines equipped with proprietary 8nm or 12nm ASIC chips under different series dedicated to the mining of KAS coins, ALPH coins, and RXD coins. The Company operated in two reportable segments, which were the cryptocurrency mining and the sale of mining machines Key revenue is generated from Sale of mining machines. Geographically, It derives key revenue from Hong Kong, China and Vietnam, United States, Singapore, etc.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: